BNA, the leading provider of expert information and analysis, presents a one-day, information-packed conference entitled Pharmaceutical Patent Law: A Prescription for Success in Challenging Times. The conference will be held at the Ritz-Carlton, Pentagon City, 1250 South Hayes Street, Arlington, VA, on November 12, 2008. BNA offers a prescription for success as legislative, judicial, administrative, […]

Today the PTO published a notice in the Federal Register inviting public comments on paperwork burdens associated with the Ex parte Appeal Rule (73 Fed. Reg. 32937-32977, June 10, 2008).  This Information Collection Request (ICR)  an application from an agency to OMB for OMB’s approval under Paperwork Reduction Act, giving the agency authority to collect information […]

The Biotechnology Institute is now accepting applications for “BioNOW” (Biotechnology Network of Women,) a leadership training program for women biotechnology professionals. The Biotechnology Institute is partnering with biopharmaceutical company Nektar Therapeutics for the program. BioNOW, which will be held December 4-5 at Nektar’s headquarters in San Carlos, CA, will allow participants to develop skills that […]

This summer I went on vacation for a few days to get away from the office, computers, and patent law.  Yet I couldn’t help but to bring a little work with me.  Only this time it wasn’t something I could bill a few hours for; it was the thriller Undue Diligence written by Paul Haughey, […]

Earlier, Dr. Triantafyllos Tafas’ lawsuit, arguing that the proposed U.S. Patent Office continuation rules are void for exceeding its authority, won a permanent injunction prohibiting the USPTO from putting the new rules changes into effect (Final Rules; 72 Federal Register 161 at 46716).  Tafas v. Dudas and the United States Patent and Trademark Office. Dr. […]

BIO’s Intellectual Property Counsel Committee is holding its Fall Conference and Committee Meeting on Oct. 20-22, 2008, at the Hard Rock Hotel at Universal Orlando, Orlando, Florida. BIO’s semi-annual IP Counsels’ Committee Conference is an excellent opportunity for BIO members to hear, listen, and learn about current and projected topics related to biotechnology IP. In […]

Yes, the country’s financial system may be in total meltdown right now but your company can still benefit from the Global Cardiovascular Innovation Center (GCIC).  On top of developing and acquiring new technologies, the GCIC also looks to launch new cardio companies and recruit companies with $30 million in investable cash. The GCIC has announced […]